The market for ischemia-reperfusion injury therapeutics is anticipated to expand at a CAGR of 6.2% during the forecast period of 2023 to 2031. Reperfusion injury, also known as Ischemia-Reperfusion Injury, is the tissue damage that occurs when blood supply returns to ischemic tissue. Increased tissue damage and fluid filtration across the tissue are the primary factors driving the market's expansion.
Nutraceutical is a combined term for nutrition and pharmaceutical products that claim to exhibit immense health benefits. Considerable interest for nutraceuticals grew due to the bioactive components of nutraceuticals that have additive nutritional value to human health. Increasing economies of developing nations along with countries with emerging economies is expected to expand the nutraceuticals industry.
With ring trend towards self-administration of drugs, injectable drug delivery solutions such as autoinjectors and pen injectors demonstrate a noteworthy growth potential in the near future. Driven by industry demands, the biopharmaceutical companies worldwide have since introduced a big range of drug injection solutions. In fact, it is also estimated that a significant section of new product entries to the FDA will be drug-device combinations.
